{"title":"Bilateral Testicular Tumors Recurred 5 Years After Surgery for an Extragonadal Germ Cell Tumor: Case Report.","authors":"Hiraku Yamamoto, Isao Hara, Satoshi Muraoka, Takahito Wakaymiya, Shimpei Yamashita, Yasuo Kohjimoto","doi":"10.1002/iju5.70190","DOIUrl":"https://doi.org/10.1002/iju5.70190","url":null,"abstract":"<p><strong>Introduction: </strong>Extragonadal germ cell tumors (EGCT) account for approximately 3%-7% of all germ cell tumors. Metachronous testicular tumors develop in 5%-7% of patients after EGCT treatment; however, bilateral testicular tumors have not been reported.</p><p><strong>Case presentation: </strong>A 30-year-old man underwent retroperitoneal tumor resection and was diagnosed as teratoma. A cystic lesion in the right testis without malignant features was managed by surveillance. Five years later, he presented with left testicular discomfort. Imaging revealed bilateral testicular tumors, and serum hCG was elevated (11.9 mIU/mL). Bilateral radical orchiectomy revealed pure seminoma (pT1) in the left testis and mixed germ cell tumor with seminoma and teratoma components (pT1) in the right testis.</p><p><strong>Conclusions: </strong>This is the first reported case of bilateral testicular tumors developing after EGCT treatment. In patients with EGCT, the potential presence of testicular germ cell neoplasia in situ should be considered, and long-term follow-up is recommended.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70190"},"PeriodicalIF":0.0,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13136946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IJU Case ReportsPub Date : 2026-05-04eCollection Date: 2026-05-01DOI: 10.1002/iju5.70182
Moe Toyoshima, Shigekatsu Maekawa, Arisa Machida, Kie Sekiguchi, Daiki Ikarashi, Renpei Kato, Mitsugu Kanehira, Jun Sugimura, Wataru Obara
{"title":"Essential Renal Bleeding Presenting as Persistent Unilateral Hematuria Successfully Treated With Factor XIII Replacement Therapy: A Case Report.","authors":"Moe Toyoshima, Shigekatsu Maekawa, Arisa Machida, Kie Sekiguchi, Daiki Ikarashi, Renpei Kato, Mitsugu Kanehira, Jun Sugimura, Wataru Obara","doi":"10.1002/iju5.70182","DOIUrl":"https://doi.org/10.1002/iju5.70182","url":null,"abstract":"<p><strong>Introduction: </strong>Essential renal bleeding is rare and lacks standardized treatment; organ-preserving options are critical in older patients with impaired renal function.</p><p><strong>Case presentation: </strong>A woman in her early 80s with atrial fibrillation treated with edoxaban, chronic heart failure, and advanced chronic kidney disease presented with gross hematuria and bladder tamponade. Bleeding was localized to the right renal pelvis and ureter, with no tumor, urolithiasis, vascular malformation, or glomerular disease; essential renal bleeding was diagnosed. Hematuria persisted despite edoxaban discontinuation, red blood cell and plasma transfusions, and carbazochrome sodium sulfonate administration. Isolated factor XIII activity was 22%. Intravenous plasma-derived factor XIII concentrate achieved sustained hemostasis, renal function remained stable, and reduced-dose edoxaban was safely resumed. Hematuria did not recur within 24 months.</p><p><strong>Conclusion: </strong>In this population, factor XIII deficiency may contribute to persistent unilateral hematuria despite normal conventional coagulation tests.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70182"},"PeriodicalIF":0.0,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Metastasis of Hepatocellular Carcinoma to the Urinary Bladder: A Case Report and Literature Review.","authors":"Eri Fukagawa, Suguru Oka, Kazushige Sakaguchi, Shigeki Yamamoto, Masako Ikemura, Norio Akuta, Shinji Urakami","doi":"10.1002/iju5.70189","DOIUrl":"https://doi.org/10.1002/iju5.70189","url":null,"abstract":"<p><strong>Introduction: </strong>Although secondary bladder tumors from distant metastases are rare, those originating from hepatocellular carcinoma are particularly uncommon, with only a few cases reported to date.</p><p><strong>Case presentation: </strong>An 81 year old male with hepatocellular carcinoma developed a rapidly growing 23 mm-sized bladder tumor during systemic therapy with atezolizumab and bevacizumab. Cystoscopy revealed a pedunculated, nonpapillary tumor on the posterior wall of the bladder, and transurethral resection was urgently performed due to bleeding. Histopathology and immunohistochemistry confirmed bladder metastasis of hepatocellular carcinoma.</p><p><strong>Conclusion: </strong>Although rare, rapidly enlarging bladder tumors in patients with hepatocellular carcinoma should be considered as possible metastatic lesions in the differential diagnosis.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70189"},"PeriodicalIF":0.0,"publicationDate":"2026-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13136500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147845998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IJU Case ReportsPub Date : 2026-04-28eCollection Date: 2026-05-01DOI: 10.1002/iju5.70186
Fredrik Liedberg, Mats Bläckberg, Johannes Bobjer
{"title":"Secondary Colonic Adenocarcinoma After Continent Cutaneous Urinary Diversion a.m. Lundiana-An Aggressive Disease Entity With High Risk of Locally Advanced Disease and Metastases.","authors":"Fredrik Liedberg, Mats Bläckberg, Johannes Bobjer","doi":"10.1002/iju5.70186","DOIUrl":"https://doi.org/10.1002/iju5.70186","url":null,"abstract":"<p><strong>Introduction: </strong>We herein report two patients developing secondary adenocarcinomas arising in colonic segments used for urinary diversion a.m. Lundiana in a population-based series 16 and 27 years after cystectomy, respectively.</p><p><strong>Case presentation: </strong>Following initial partial resection of the pouch, both patients experienced local recurrence; one subsequently developed distant metastases and died from secondary adenocarcinoma, whereas the other patient underwent extirpation of the pouch and re-diversion with an ileal conduit.</p><p><strong>Conclusions: </strong>Based on these patients, upfront radical surgery would have been a more effective treatment. In this patient population, clinical awareness but not screening for secondary adenocarcinomas seems to be the most appropriate strategy.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70186"},"PeriodicalIF":0.0,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13122120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Case of Testicular Malakoplakia With Markedly High Signal Intensity on Fat-Suppressed T1-Weighted Images.","authors":"Fumiko Yagi, Hirotaka Akita, Takeo Kosaka, Akihisa Ueno, Teppei Kotera, Masato Kobayashi, Hideaki Mekada, Mototsugu Oya, Masahiro Jinzaki","doi":"10.1002/iju5.70187","DOIUrl":"https://doi.org/10.1002/iju5.70187","url":null,"abstract":"<p><strong>Introduction: </strong>Testicular malakoplakia is a very rare, chronic granulomatous inflammatory condition that frequently resembles testicular malignancy on imaging studies. Here, we report a case of testicular malakoplakia with characteristic magnetic resonance imaging (MRI) findings and present a brief review of the literature.</p><p><strong>Case presentation: </strong>A man in his 70s presented with left-sided scrotal pain. Ultrasonography revealed a well-defined hypoechoic intratesticular mass without internal vascularity, whereas computed tomography revealed enlargement of the left testis with a relative hyperattenuation area. MRI demonstrated low signal intensity on T2-weighted images, diffusion restriction, and a markedly high signal intensity on fat-suppressed T1-weighted images with contrast enhancement. Based on these findings, a malignant testicular tumor was suspected, and radical orchidectomy was conducted. Histopathological examination confirmed testicular malakoplakia with characteristic Michaelis-Gutmann bodies.</p><p><strong>Conclusion: </strong>This case highlights the importance of recognizing T1 shortening on fat-suppressed T1-weighted MRI as a potential imaging modality for malakoplakia.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70187"},"PeriodicalIF":0.0,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13112069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Maribavir for Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients: A Case Series.","authors":"Daiji Takamoto, Yu Shimada, Yuri Hasegawa, Takeaki Noguchi, Takashi Kawahara, Junichi Teranishi, Kazuhide Makiyama","doi":"10.1002/iju5.70183","DOIUrl":"https://doi.org/10.1002/iju5.70183","url":null,"abstract":"<p><strong>Background: </strong>Cytomegalovirus (CMV) infection remains a common complication after kidney transplantation, particularly among high-risk donor-seropositive/recipient-seronegative (D+/R-) recipients. Valganciclovir is the standard first-line therapy; however, its use may be limited by hematological toxicity or impaired graft function. Maribavir is a recently approved antiviral agent with a distinct mechanism of action.</p><p><strong>Case presentation: </strong>We report four high-risk kidney transplant recipients in whom maribavir was introduced because continued valganciclovir therapy was difficult owing to cytopenia or renal dysfunction. After switching therapy, CMV viral loads decreased in all cases, and hematological abnormalities improved following discontinuation of valganciclovir. One patient developed a drug-induced skin eruption, while no other serious adverse events were observed. No CMV recurrence or graft dysfunction occurred during follow-up.</p><p><strong>Conclusion: </strong>These cases highlighted practical clinical considerations for managing CMV infection when standard antiviral therapy cannot be safely continued.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70183"},"PeriodicalIF":0.0,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13112181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
IJU Case ReportsPub Date : 2026-04-21eCollection Date: 2026-05-01DOI: 10.1002/iju5.70184
{"title":"Correction to \"Robot-Assisted Partial Nephrectomy via a Retroperitoneal Approach With Selective Arterial Clamping Guided by Blood Flow Analysis in a Horseshoe Kidney: A Case Report\".","authors":"","doi":"10.1002/iju5.70184","DOIUrl":"https://doi.org/10.1002/iju5.70184","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1002/iju5.70178.].</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70184"},"PeriodicalIF":0.0,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13099363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Requiring Caution in the Interpretation of Donor-Derived Cell-Free DNA Levels During Cancer Treatment in a Kidney Transplant Recipient.: A Case Report.","authors":"Nanaka Katsurayama, Toshihito Hirai, Yu Kijima, Hiroki Ishihara, Hironori Fukuda, Kazuya Omoto, Tomokazu Shimizu, Masashi Inui, Hideki Ishida, Toshio Takagi","doi":"10.1002/iju5.70180","DOIUrl":"10.1002/iju5.70180","url":null,"abstract":"<p><strong>Introduction: </strong>Donor-derived cfDNA (dd-cfDNA) indicates allograft rejection when > 1% of total cfDNA, but tumor-derived cfDNA can interfere in cancer patients.</p><p><strong>Case presentation: </strong>A 61-year-old male kidney transplant recipient with metastatic renal cell carcinoma (RCC) initiated avelumab and axitinib. Following two cycles of Immno-oncology (IO) therapy, serum creatinine (Cr) levels increased to 3.1 mg/dL. Although %dd-cfDNA remained below the conventional 1% threshold, it rose to 0.41%, representing a relative change value (RCV) of +178% from baseline. Two weeks later, Cr increased to 4.5 mg/dL, accompanied by severe hyponatremia, necessitating discontinuation of IO therapy, treated with methylprednisolone and resumed IO therapy; however, Cr remained elevated; he required hemodialysis.</p><p><strong>Conclusion: </strong>RCV from baseline %dd-cfDNA may serve as a more reliable indicator of allograft injury, facilitating earlier intervention in transplant recipients undergoing IO therapy.</p>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 ","pages":"e70180"},"PeriodicalIF":0.0,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13090116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147724518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Takashi Fujita, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Fumihiro Ito
{"title":"Robot-Assisted Partial Nephrectomy via a Retroperitoneal Approach With Selective Arterial Clamping Guided by Blood Flow Analysis in a Horseshoe Kidney: A Case Report","authors":"Takashi Fujita, Koki Kobayashi, Gaku Hayashi, Shunsuke Kamijo, Fumihiro Ito","doi":"10.1002/iju5.70178","DOIUrl":"10.1002/iju5.70178","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Horseshoe kidney is the most common congenital renal fusion anomaly and is associated with aberrant anatomy and a complex vascular supply, which can complicate nephron-sparing surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 43-year-old woman was incidentally diagnosed with a small hypovascular tumor in the right renal moiety of a horseshoe kidney. Three-dimensional computed tomography with blood flow analysis using SYNAPSE VINCENT (Fujifilm, Japan) demonstrated that the tumor was supplied exclusively by the upper pole renal artery. Because the right renal moiety was largely covered by the liver, a conventional midaxillary retroperitoneal approach was unsuitable, and the retroperitoneal space was established via a pararectus approach. A hybrid laparoscopic–robotic technique was adopted due to the limited working space.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Preoperative blood flow analysis enabled selective arterial clamping, and a tailored surgical approach allowed safe robot-assisted partial nephrectomy with minimal blood loss and preserved renal function.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13058432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147647305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Central Adrenal Insufficiency Developing After Right Partial Nephrectomy Involving Ectopic Adrenocortical Adenoma Mimicking Right Renal Carcinoma and a Retrospective Diagnosis of Adrenal Cushing's Syndrome: A Case Report","authors":"Kentaro Arinami, Sayaka Kikuchi, Nobumasa Ohara, Yurie Takizawa, Yohei Ikeda, Kozue Ito, Go Hasegawa, Noboru Hara, Tsutomu Nishiyama","doi":"10.1002/iju5.70172","DOIUrl":"10.1002/iju5.70172","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Ectopic adrenocortical adenomas that produce adrenal hormones and mimic renal cell carcinoma are extremely rare.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 49-year-old woman underwent partial nephrectomy of the upper pole of the kidney following a clinical diagnosis of renal cell carcinoma. The tumor, initially suspected to be renal cell carcinoma, was definitively diagnosed as an ectopic adrenocortical adenoma producing adrenocortical hormones, which was removed surgically. Postoperatively, she developed tertiary adrenal insufficiency. After hydrocortisone therapy, the patient's symptoms gradually improved, and laboratory results also showed improvement. Retrospectively, the patient exhibited signs of Cushing's syndrome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>If the patient's body habitus suggests Cushing's syndrome, it is important to conduct an endocrinological evaluation before surgery. Additionally, early postoperative monitoring and glucocorticoid supplementation should be performed if necessary.</p>\u0000 </section>\u0000 </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"9 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13052496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147634782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}